Literature DB >> 16601298

PTH(1-84)/PTH(7-84): a balance of power.

Peter A Friedman1, William G Goodman.   

Abstract

This review considers many new basic and clinical aspects of parathyroid hormone (PTH). We focus especially on the identification of PTH fragments and how they may relate to renal failure, diagnosis, and treatment of secondary hyperparathyroidism and renal osteodystrophy. The biosynthesis and metabolism of PTH, measurement of circulating forms of PTH, the effects of PTH on receptor activation and turnover, the relationship between PTH levels and bone turnover in renal failure in humans, and the involvement of PTH in experimental models of renal failure are discussed. Despite these developments in understanding the etiology of renal failure and the availability of new assays for bioactive PTH, no adequate surrogate for bone biopsy and quantitative bone histomorphometry has been developed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16601298     DOI: 10.1152/ajprenal.00336.2005

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  10 in total

1.  Safety, tolerability and pharmacokinetic study of recombinant human parathyroid hormone [rhPTH (1-84)] in Chinese healthy volunteers.

Authors:  Qian Li; Jian Qiao; Jungang Deng; Tianshu Zeng; Piqi Zhou; Weiyong Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-08-07

Review 2.  Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism.

Authors:  Esther S Kim; Gillian M Keating
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

3.  Can the combination of calcium and parathormone levels above K/DOQI guidelines be used as a marker of adynamic bone disease in African Americans?

Authors:  Charles J Diskin; Thomas J Stokes; Linda M Dansby; Lautrec Radcliff; Thomas B Carter
Journal:  Int Urol Nephrol       Date:  2010-06-12       Impact factor: 2.370

4.  Site-specific polyubiquitination differentially regulates parathyroid hormone receptor-initiated MAPK signaling and cell proliferation.

Authors:  Qiangmin Zhang; Kunhong Xiao; Hongda Liu; Lei Song; Jennifer C McGarvey; W Bruce Sneddon; Alessandro Bisello; Peter A Friedman
Journal:  J Biol Chem       Date:  2018-02-14       Impact factor: 5.157

Review 5.  Regulation of parathyroid function in chronic kidney disease (CKD).

Authors:  Masafumi Fukagawa; Shohei Nakanishi; Hideki Fujii; Yasuhiro Hamada; Takaya Abe
Journal:  Clin Exp Nephrol       Date:  2006-09       Impact factor: 2.801

6.  Pharmacodynamic model of parathyroid hormone modulation by a negative allosteric modulator of the calcium-sensing receptor.

Authors:  Anson K Abraham; Tristan S Maurer; Amit S Kalgutkar; Xiang Gao; Mei Li; David R Healy; Donna N Petersen; David A Griffith; Donald E Mager
Journal:  AAPS J       Date:  2011-03-25       Impact factor: 4.009

7.  TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling.

Authors:  Tao Qiu; Xiangwei Wu; Fengjie Zhang; Thomas L Clemens; Mei Wan; Xu Cao
Journal:  Nat Cell Biol       Date:  2010-02-07       Impact factor: 28.824

Review 8.  The kidney and bone metabolism: Nephrologists' point of view.

Authors:  Masafumi Fukagawa; Yasuhiro Hamada; Shohei Nakanishi; Motoko Tanaka
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 9.  Parathyroid hormone/parathyroid hormone-related peptide regulate osteosarcoma cell functions: Focus on the extracellular matrix (Review).

Authors:  Dragana Nikitovic; Rafaela-Maria Kavasi; Aikaterini Berdiaki; Dionysios J Papachristou; John Tsiaoussis; Demetrios A Spandidos; Aristides M Tsatsakis; George N Tzanakakis
Journal:  Oncol Rep       Date:  2016-08-01       Impact factor: 3.906

10.  Higher Proportion of Non-1-84 PTH Fragments in Peritoneal Dialysis Patients Compared to Hemodialysis Patients Using Solutions Containing 1.75 mmol/l Calcium.

Authors:  Carmen Sánchez-González; Maria Luisa Gonzalez-Casaus; Víctor Lorenzo Sellares; Marta Albalate; José-Vicente Torregrosa; Sebastian Mas; Alberto Ortiz; Mariano Rodriguez; Emilio Gonzalez-Parra
Journal:  Front Physiol       Date:  2018-11-20       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.